Loading cancer entity…
Loading cancer entity…
Clinical trials
101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06432556 | Study of Cellular Heterogeneity in Patients With Mastocytosis(MastCellHet) | unknown | N/A | 26 | University Hospital, ToulouseOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT04655118 | Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis | unknown | Phase 2 | 121 | Telios Pharma, Inc.INDUSTRY | 13 | May 10, 2024 | clinicaltrials |
| NCT05504408 | Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia | unknown | — | 200 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06013683 | A Registry for Patients With Systemic Mastocytosis in China | unknown | — | 150 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05923372 | Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis(DALY-MAST) | unknown | — | 160 | University Hospital, ToulouseOTHER | 1 | Jul 12, 2023 | clinicaltrials |
| NCT04333108 | Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment | unknown | Phase 3 | 140 | AB ScienceINDUSTRY | 8 | May 6, 2023 | clinicaltrials |
| NCT05084872 | Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients(HCQMa) | unknown | Phase 2 / Phase 3 | 30 | University Hospital, ToulouseOTHER | 1 | Oct 20, 2021 | clinicaltrials |
| NCT04615663 | Assessment of Burden Disease in Patients With Mast Cell Disorders(MCD&BuDi) | unknown | — | 200 | University Hospital, ToulouseOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04377828 | Improvement of Pigmented Skin Lesions in Patients With Mastocytosis After Performing 2 Sessions of Pigment Laser(LaserMasto) | unknown | N/A | 34 | University Hospital, ToulouseOTHER | 1 | Sep 25, 2020 | clinicaltrials |
| NCT03340155 | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases(BioUV2017) | unknown | N/A | 240 | Medical University of GrazOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01602939 | Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis | unknown | Phase 2 / Phase 3 | 10 | Hospital Virgen de la SaludOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01920204 | Midostaurin in Indolent Systemic Mastocytosis | unknown | Phase 2 | 20 | University Medical Center GroningenOTHER | 1 | Jan 19, 2015 | clinicaltrials |
| NCT00979160 | Evaluation of Response of Dasatinib to Treat Mastocytosis | unknown | Phase 2 | 30 | Federico II UniversityOTHER | 1 | Sep 18, 2009 | clinicaltrials |
Data updated 22 days agoSource updated May 29, 2024source: clinicaltrials